Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Kevin Ott, executive director of the Bio-Process Systems Alliance, discusses the latest trends and issues surrounding single-use technologies and the role of his association.

Growth of Bio-Process Systems Alliance Reflects Rising Interest in Single-Use Technologies

AAIPharma Services CEO Patrick Walsh talks about the parenterals market and the drivers for his company's recent expansion of its sterile-manufacturing capabilities.

AAIPharma CEO Discusses Parenteral Manufacturing

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended Sanofi's six-in-one pediatric vaccine for marketing authorization.

Sanofi's Six-In-One Pediatric Vaccine Recommended for European Approval

Merck and Samsung Bioepis have formed an agreement to develop and commercialize multiple prespecified and undisclosed biosimilar candidates.

Merck and Samsung Bioepis Form Biosimilars Development and Commercialization Agreement

Amy Ritter was Scientific Editor, BioPharm International.

Protein Sciences announced that the Biomedical Advanced Research and Development Authority (BARDA) will continue to support the company?s influenza vaccines program.

BARDA Continues to Support Protein Sciences' Cell-Based Vaccine Programs

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The share of biologic-based drugs in the global pharmaceutical market is on the rise.

Tracking Growth in Biologics

The Latest in Tableting and Granulation

Adopting a seven-step process to maintenance and storage improves tableting quality.

Solving Tableting and Tooling Problems

Mark Copley is Sales Director at Copley Scientific.

Even in an industry in which all product development is complicated by the intricacies of human biology, orally inhaled products (OIP) stand out as singularly demanding.

Improving Inhaled Product Testing: Methods for Obtaining Better In vitro-In vivo Relationships

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

GlaxoSmithKline has formed a joint venture with Indian vaccines company Biological E to research and develop a six-in-one combination pediatric vaccine to help protect children in India and other developing countries from certain infectious diseases.